OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
UHEA50

Unihealth Hospitals Ltd

Healthcare Facilities & ServicesVerified

Unihealth Hospitals Ltd has a basic capital structure with no dilution risk, as the number of basic and diluted shares outstanding is identical at 15,699,952. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison with industry benchmarks, as the valuation snapshot does not include computed ratios such as ROIC or margins. This lack of data limits the ability to assess the company's performance relative to its peers in the healthcare facilities and services industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to evaluate the diversification of its revenue streams or the risks associated with regional market exposure. Growth trajectory data is also unavailable, as the outlook section does not provide numeric deltas or revenue history. This absence of forward-looking guidance and historical performance data hinders the ability to assess the company's growth potential or trajectory. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, but the lack of balance-sheet inputs and going-concern language in source documents raises concerns about the company's financial health and transparency. Recent events and filings have not been disclosed in the available data, so no specific recent developments can be reported. The absence of recent transcripts or filings limits the ability to assess the company's current strategic direction or operational performance.

30-day price · UHEA+82.05 (+21.6%)
Low$362.20High$529.80Close$462.55As of17 May, 00:00 UTC
Profile
CompanyUnihealth Hospitals Ltd
TickerUHEA.NS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Unihealth Hospitals Ltd has a basic capital structure with no dilution risk, as the number of basic and diluted shares outstanding is identical at 15,699,952. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison with industry benchmarks, as the valuation snapshot does not include computed ratios such as ROIC or margins. This lack of data limits the ability to assess the company's performance relative to its peers in the healthcare facilities and services industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to evaluate the diversification of its revenue streams or the risks associated with regional market exposure. Growth trajectory data is also unavailable, as the outlook section does not provide numeric deltas or revenue history. This absence of forward-looking guidance and historical performance data hinders the ability to assess the company's growth potential or trajectory. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, but the lack of balance-sheet inputs and going-concern language in source documents raises concerns about the company's financial health and transparency. Recent events and filings have not been disclosed in the available data, so no specific recent developments can be reported. The absence of recent transcripts or filings limits the ability to assess the company's current strategic direction or operational performance.
Key takeaways
  • The company has no dilution risk as basic and diluted shares are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data.
  • Profitability and return metrics are not available for comparison with industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed.
  • Growth trajectory and historical performance data are unavailable.
  • Recent events and filings are not disclosed, limiting insight into current operations.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$262.1M$66.0M$50.1M$67.8M
FY-3$368.3M$116.5M$38.2M$47.0M
FY-2$439.4M$146.8M$76.8M$78.5M
FY-1$487.5M$209.9M$103.1M$102.7M
FY0$555.9M$212.1M$151.4M$78.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$583.9M$107.0M
FY-3$647.9M$147.9M
FY-2$783.3M$275.2M
FY-1$1.10B$854.5M
FY0$1.32B$1.03B
PeriodOCFCapExFCFSBC
FY-4$40.6M-$3.6M$67.8M
FY-3$92.7M-$13.0M$47.0M
FY-2$13.3M-$23.2M$78.5M
FY-1$46.8M-$23.8M$102.7M
FY0-$32.6M-$98.4M$78.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricUHEAActivity
Op margin5.6% medp25 -4.2% · p75 12.6%
Net margin2.8% medp25 -3.4% · p75 8.8%
Gross margin36.5% medp25 23.7% · p75 65.2%
CapEx / revenue-4.9% medp25 -11.5% · p75 -2.0%
Debt / equity69.3% medp25 7.9% · p75 120.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:50 UTC#43741f64
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 20:29 UTCJob: b2e41fce